The study will evaluate the safety and efficacy of the molecule IMP1734, a selective inhibitor that blocks a key enzyme for DNA repair in cancer cells.
Read moreThe team at the National Cancer Research Centre (CNIO), a world leader in paragangliomas and pheochromocytomas, is forging new pathways for the early diagnosis and personalised treatment of these canc...
Read moreEl Grupo de Inmunología Tumoral de la institución académica asturiana identifica una proteína con potencial terapéutico y pronóstico en la leucemia linfática crónica
Read moreThe journal Cancer Cell has published a study led by the Hospital del Mar Research Institute, together with researchers from GEICAM, identifying malignant cells carrying the TIM-3 protein as a central...
Read moreNurses Nuria Sánchez and Paula Calvo, from the Clinical Trials Unit of the Marqués de Valdecilla University Hospital (HUMV/IDIVAL), have participated in an international study conducted within the f...
Read moreNew assay provides clinical research labs with an all-in-one comprehensive genomic profiling solution that delivers next-day results
Read moreThe main players in this story are NK cells (short for natural killer), a type of white blood cell that patrols the body in search of abnormal cells. These cells recognize antibodies bound to tumor ce...
Read moreAIDA (An Artificially Intelligent Diagnostic Assistant for gastric inflammation) es una iniciativa europea de investigación e innovación financiada por la Unión Europea que busca transformar el abo...
Read moreEl equipo desarrollará una terapia basada en ARN, diseñada para inhibir específicamente la molécula de ARN largo no codificante (lncRNA). El objetivo es frenar el crecimiento del tumor y abrir nue...
Read moreThe study demonstrates that incorporating the HER2DX genomic test—developed by Reveal Genomics and capable of capturing both clinical and biological factors—enables better risk stratification and ...
Read moreHighlight Therapeutics and CNIO are collaborating to proof BO-112 effectiveness against the most common form of skin cancer, which is linked to sun exposure and is on the rise.
Read moreThe study, published in the journal Bioorganic Chemistry, identifies molecules capable of blocking a key interaction in the progression of this type of tumor.
Read more